Trial NCT00621036

View at ClinicalTrials.gov 
Org. Study IDs: SCCC-02F07
Secondary IDs: CDR0000587504 SCCC-102007-035

Last trial update was posted on 2018-11-26

MeSH Interventions

Antibodies Immunoglobulin Idiotypes Immunoglobulins Immunoglobulins, Intravenous Methotrexate Sargramostim Thiotepa

MeSH Conditions

Central Nervous System Neoplasms Intestinal Neoplasms Lymphoma Lymphoproliferative Disorders Nervous System Neoplasms

Other Conditions

Brain and Central Nervous System Tumors Lymphoproliferative Disorder Small Intestine Cancer

Stopping Reasons

MyVax did not meet its primary endpoints

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID